Fillmed develops, manufactures and markets medical devices and cosmetic products for aesthetic medicine professionals (aesthetic doctors, dermatologists, etc.). Today, Fillmed is world leader with a +50% market share in the mesotherapy segment, a preventive and minimally invasive treatment that nourishes and stimulates skin in order to improve its quality. Its position gives it a strong legitimacy and visibility in the medical field.

In 2010, HLD and Didier Tabary jointly took control of Laboratoires Filorga, within which the cosmetics business (Filorga Cosmétique) and the medical business (Fillmed) were consolidated. In 2015, the two companies were separated with the aim of establishing a specific strategy per activity.

Filorga Cosmetics has been disposed to Colgate in 2019.

Today, HLD supports actively Fillmed's international development and product innovations.